Metaraminol
Systematic (IUPAC) name | |
---|---|
(1R,2S)-3-[-2-amino-1-hydroxy-propyl]phenol | |
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Pregnancy category | |
Routes of administration | Intravenous |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | n/a |
Protein binding | ~45% |
Metabolism | Hepatic |
Identifiers | |
CAS Number |
54-49-9 33402-03-8 (bitartrate) |
ATC code | C01CA09 (WHO) |
PubChem | CID 5906 |
IUPHAR/BPS | 7229 |
DrugBank | DB00610 |
ChemSpider | 5695 |
UNII | 818U2PZ2EH |
KEGG | D08192 |
ChEBI | CHEBI:6794 |
ChEMBL | CHEMBL1201319 |
Chemical data | |
Formula | C9H13NO2 |
Molar mass | 167.205 g/mol |
| |
| |
(what is this?) (verify) |
Metaraminol (INN; trade names Aramine, Metaramin, and Pressonex), also known as metaradrine, a stereoisomer of meta-hydroxynorephedrine (3,β-dihydroxyamphetamine), is a potent sympathomimetic amine used in the prevention and treatment of hypotension, particularly as a complication of anesthesia. It is an α1-adrenergic receptor agonist with some β effect.[1]
Metaraminol is also used in the treatment of priapism. Although not approved for this use, it appears to be effective.[2][3][4]
See also
References
- ↑ Kee VR. Hemodynamic pharmacology of intravenous vasopressors. Crit Care Nurse. 2003 Aug;23(4):79-82. PMID 12961786
- ↑ McDonald M, Santucci R (2004). "Successful management of stuttering priapism using home self-injections of the alpha-agonist metaraminol.". Int Braz J Urol 30 (2): 121–2. doi:10.1590/S1677-55382004000200007. PMID 15703094.
- ↑ Koga S, Shiraishi K, Saito Y (1990). "Post-traumatic priapism treated with metaraminol bitartrate: case report.". J Trauma 30 (12): 1591–3. doi:10.1097/00005373-199012000-00029. PMID 2258979.
- ↑ Block T, Sturm W, Ernst G, Staehler G, Schmiedt E (1988). "[Metaraminol in therapy of various forms of priapism]". Urologe A 27 (4): 225–9. PMID 3140463.
|
|
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.